Pharmaron Beijing Co., Ltd.

HKEX
3759
Stock
Yield per half year: +69.74%
Dividend yield: 1.33%
Sector: Healthcare

Pharmaron Beijing Co., Ltd.

28.0028.0024.0024.0020.0020.0016.0016.0012.0012.008.008.00Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
13.17 -27.77 -147.43% 49.22 -73.24%
P/S 1.92 54.94 -96.5%
P/BV 1.66 3.06 -45.8%
P/FCF 69.85 15.9 339.37%
Ev/Ebitda 21.05 28.92 -27.22%
Ev/S 2.21 -0.5462 -503.77%
Ev/FCF 50.51 -7.03 -818.16%
E/P 0.0479 0.0191 151.33%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
20.61 -262.41 -107.85% 26.81 -23.13%
ROE 13.7 -5.11 -368.37%
ROA 7.12 0.2788 2452.32%
ROIC 0 0 0%
ROS 14.61 -266.12 -105.49%
ROCE 0 0.6626 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
6/10
2.03 0.5873 246.1% 2.31 -11.92%
Nеt Debt/Ebitda 1.36 -1.27 -207.23%
Debt/Ratio 0.2149 0.1352 58.96%
Debt/Equity 0.6823 0.8667 -21.27%
Debt/Net Income 2.87 2.28 25.92%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.33/10
1.33 2.97 -55.23% 1.43 -6.86%
Number of years of dividend growth 0 1.26 -100%
DSI 0.75 0.5452 37.55%
Average dividend growth 20.25 8.21 146.63%
Average percentage for 5 years 1.43 3.04 -53.05%
Average percentage for payments 26.73 34.24 -21.95%
Difference from average difference in sector -1.64

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
119.92 14.18 745.7%
Growth impulse Ebitda in 5 years 90.83 64.12 41.66%
Growth impulse Net Income in 5 years 40.74 22.8 78.68%
Growth impulse FCF in 5 years 48.15 146.59 -67.15%
Growth impulse EPS in 5 years -13.49 -78.65 -82.85%
IP Score
5.45/10

Similar companies

Hangzhou Tigermed Consulting Co., Ltd

WuXi Biologics (Cayman) Inc.

CSPC Pharmaceutical Group Limited

WuXi AppTec Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription